Abstracts Archive - Page 2360 of 2607 - ACR Meeting Abstracts

Abstract Number: 1081 • 2013 ACR/ARHP Annual Meeting
The Effects of Coexisting Cervical Myofascial Pain Syndromes On Pain and Disability of the Computer Users With Cumulative Trauma Disorders
Hakan Genc¹, Ozgul Bozkurt Tuncer², Hatice Rana Erdem³, Baris Nacir¹, Aynur Karagoz¹ and Burcu Duyur Cakit¹, ¹Department of Physical Medicine and Rehabilitation, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey, ²Department of Physical Medicine and Rehabilitation, Ministry of Health, Yuksekova Public Hospital, Hakkari, Turkey, ³Department of Physical Medicine and Rehabilitation, Ahi Evran University, Kirsehir, Turkey
Background/Purpose: Coexisting cervical myofascial pain syndromes (MPS) can have serious effects on pain and disability of computer users with cumulative trauma disorders (CTD). The aims of…
Abstract Number: 1082 • 2013 ACR/ARHP Annual Meeting
The Effects of Prolotherapy in Patients With Subacromial Impingement Syndrome
Eylem Akcan Hannan¹, Akyuz Gulseren Sr.² and Nertila Hysenaj³, ¹Department of Physical Medicine and Rehabilitation, Marmara Univesrsity School of Medicine, Istanbul, Turkey, ²Dept of Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey, ³Department of Radiology, Private Vital Hospital, Istanbul, Turkey
Background/Purpose: Recent treatments for subacromial impingement syndrome (SIS) are palliative. Dextrose injection which is called prolotherapy has emerged as a treatment option for chronic situations…
Abstract Number: 1083 • 2013 ACR/ARHP Annual Meeting
Something Ventured, Something Gained: Alternative Therapies For FMS and RA
Robert S. Katz¹, Hannah Bond², Jessica L. Polyak², Lauren Kwan², Alexandra Small³ and Susan Shott⁴, ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL, ³University of Illinois Medical School, Chicago, IL, ⁴Rush University Medical Center, Chicago, IL
Background/Purpose: Many patients with rheumatologic diseases resort to unproven alternative therapies. We compared FMS and RA patients with respect to the use and effectiveness…
Abstract Number: 1084 • 2013 ACR/ARHP Annual Meeting
Age Distribution of Women With Idiopathic and Traumatic Fibromyalgia
Robert S. Katz¹ and Frank Leavitt², ¹Rush Medical College, Chicago, IL, ²Rush University Medical Center, Chicago, IL
Background/Purpose: Fibromyalgia has both idiopathic and post traumatic forms. The idiopathic type is insidious in onset, becoming established without a known triggering event. The post-traumatic…
Abstract Number: 1085 • 2013 ACR/ARHP Annual Meeting
I Work Out: Exercise Appears To Increase FMS Pain
Robert S. Katz¹, Ben J. Small² and Susan Shott³, ¹Rush Medical College, Chicago, IL, ²Rush University Medical School, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: A basic tenet of the treatment of FMS is that exercise decreases symptoms of the illness. We compared FMS and RA patients to assess…
Abstract Number: 1086 • 2013 ACR/ARHP Annual Meeting
The Straight Neck in Fibromyalgia
Robert S. Katz¹ and Anthony Farkasch², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: In patients with fibromyalgia a straight neck is based on calculating the Cobb angle, a standard radiographic measurement, of lateral view radiographs of the…
Abstract Number: 1087 • 2013 ACR/ARHP Annual Meeting
Abnormalities Of Central Processing Mechanisms In Fibromyalgia
Robert S. Katz¹ and Bhagwan T. Shahani², ¹Rush Medical College, Chicago, IL, ²University of Illinois College of Medicine, Chicago, IL
Background/Purpose: Fibromyalgia may be associated with central pain processing abnormalities, including central sensitization. In this study, we describe three patients, two females (41 and 48…
Abstract Number: 1088 • 2013 ACR/ARHP Annual Meeting
Fibromyalgia and Parental Medical Histories Of Depression and Alcoholism
Robert S. Katz¹, Ben J. Small², Sharon M. Ferbert³ and Susan Shott⁴, ¹Rush Medical College, Chicago, IL, ²Rush University Medical School, Chicago, IL, ³Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL, ⁴Rush University Medical Center, Chicago, IL
Background/Purpose: We had found in a previous study suggestions of an increased prevalence of depression in the mothers and alcohol abuse in the fathers of…
Abstract Number: 1089 • 2013 ACR/ARHP Annual Meeting
Synergistic Effects Of Transcranial Direct Current Stimulation and Trigger Point Injection For Treatment Of Myofascial Pain Syndrome: A Pilot Study With Randomized, Single-Blinded Trial
Shi-Uk Lee¹, Chang Han Lee¹ and Yoon-Hee Choi², ¹Physical Medicine & Rehabilitation, Seoul National University Boramae Medical Center, Seoul, South Korea, ²Physical Medicine & Rehabilitation, Seoul National University Bundang Hospital, Seoul, South Korea
Background/Purpose: Chronic pain caused by myofascial pain syndrome (MPS) results in generalized and debilitating conditions. Trigger point injection (TPI) is the mainstay of MPS management…
Abstract Number: 1090 • 2013 ACR/ARHP Annual Meeting
Suprascapular Nerve Block For Shoulder Pain In The First Year After Stroke: A Randomised Controlled Trial
Zoe Adey-Wakeling¹, Maria Crotty² and E. Michael Shanahan³, ¹Rehabilitation and Aged Care, Flinders University, Adelaide, Australia, ²Department of Rehabilitation and Aged Care, Flinders University, Adelaide, Australia, ³Rheumatology, Flinders University, Bedford Park, South Australia, Australia
Background/Purpose: Shoulder pain is a significant complication of hemiplegic stroke in at least 25% of cases. The evidence base for the treatment of hemiplegic shoulder…
Abstract Number: 1059 • 2013 ACR/ARHP Annual Meeting
Perinatal and Early Life Risk Factors For Systemic Lupus Erythematosus In a National Cohort Of Women
Christine G. Parks, Aimee D'Aloisio and Dale Sandler, Epidemiology Branch, NIH/NIEHS, Research Triangle Park, NC
Background/Purpose: Growing evidence supports the role of perinatal and early life exposures in risk for chronic adult diseases. We examined perinatal and early life environmental…
Abstract Number: 1068 • 2013 ACR/ARHP Annual Meeting
An In-Depth Analysis Of The Prevalence and Socio-Demographic Factors Associated With Lupus Nephritis In Major Industrialized Countries
Guiping Yang and Anne Tuomari, Global Health Economics and Outcome Research, Teva Pharmaceuticals, Inc., Frazer, PA
Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease with incidence and prevalence well studied and documented worldwide. Lupus nephritis (LN) is a severe…
Abstract Number: 1052 • 2013 ACR/ARHP Annual Meeting
Glucocorticosteroids and Mortality Risk In Rheumatoid Arthritis – Results Of a Population Based Study
Diane Lacaille¹, J. Antonio Avina-Zubieta^2,3, Eric C. Sayre², Michal Abrahamowicz⁴ and John Esdaile^1,5, ¹Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, ²Arthritis Research Centre of Canada, Richmond, BC, Canada, ³Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁵Medicine, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Glucocorticosteroids (GC) are frequently used in the management of rheumatoid arthritis (RA). Due to their metabolic and immunosuppressive effects, they could increase the risk…
Abstract Number: 1053 • 2013 ACR/ARHP Annual Meeting
Physician Proclivity To Use Oral Glucocorticoids Among Rheumatoid Arthritis Patients
Huifeng Yun¹, Fenglong Xie², Elizabeth S. Delzell¹, Lang Chen³, Emily Levitan¹, James Lewis⁴, Kenneth G. Saag⁵, Timothy Beukelman⁶, Kevin L. Winthrop⁷, John Baddley⁸ and Jeffrey R. Curtis⁹, ¹Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ²Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ³Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁴Medicine, University of Pennsylvania, Philadelphia, PA, ⁵Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, ⁶Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁷Dept of Infectious Disease, Oregon Health & Science University, Portland, OR, ⁸Medicine, University of Alabama at Birmingham, Birmingham, AL, ⁹University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, Birmingham, AL
Background/Purpose: It is unclear if the elevated risks of adverse events in rheumatoid arthritis (RA) patients are due to use of biologics or DMARDs, glucocorticoids…
Abstract Number: 1054 • 2013 ACR/ARHP Annual Meeting
Use Of Oral and Subcutaneous MTX In a Commercially Insured Rheumatoid Arthritis Population
Jeffrey R. Curtis¹, Fenglong Xie², Jie Zhang³, Lang Chen⁴, Huifeng Yun⁵, Michael H. Schiff⁶, Timothy Beukelman⁷ and Seth Ginsberg⁸, ¹University of Alabama at Birmingham, Birmingham, AL, ²Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ³Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁴Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁵Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ⁶Rheumatology Division, University of Colorado, Denver, CO, ⁷Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁸Creaky Joints, New York, NY
Background/Purpose: Methotrexate (MTX) is the most commonly used medication in rheumatoid arthritis (RA), although use of oral and subcutaneous (SQ) preparations in real-world settings has…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].